Recently, we reported on the induction by kirromycin of two tRNA binding sites on elongation factor Tu. To obtain independent information on the existence of these two sites and to characterize them further, 3' oxidized tRNA was cross-linked to elongation factor Tu by [3H]borohydride reduction. Specific cross-linking occurred exclusively in the presence of kirromycin. In the case of elongation factor Tu-GDP-kirromycin, cross-linking was found at lysine-208; in elongation factor Tu'GTP-kirromycin, cross-linking was at lysine-208 and lysine-237. In both elongation factor Tu complexes, kirromycin itself was found cross-linked to lysine-357. The tRNA cross-linking sites are in agreement with the idea of two different binding sites of tRNA on elongation factor Tu.
The elongation factor Tu (EF-Tu) plays a central role in protein synthesis by mediating the binding of aminoacyl-tRNA to the ribosome-mRNA complex. This capacity of EF-Tu strongly depends on the presence of two effector nucleotides: GDP and GTP (1, 2) . The latter induces a conformation that enables EF-Tu to form the ternary complex: EFTu-GTP-aminoacyl-tRNA. When GTP is replaced by GDP, the affinity of EF-Tu for aminoacyl-tRNA is reduced by several orders of magnitude (3) . The affinity of EF-Tu GTP for fMet-tRNAfmet is about 1/750th that for charged elongator tRNAs (4), while uncharged tRNAs bind only poorly as compared to aminoacyl-tRNA (3) .
Kirromycin is an antibiotic that binds to EF-Tu in an 1:1 molar ratio (5) . On binding of kirromycin, EF-Tu-GDP becomes able to form a complex with aminoacyl-tRNA (6) . Recently, we found (7) that in the presence of the antibiotic both EF-TuwGDP and EF-Tu-GTP also bind uncharged tRNA and N-acetylaminoacyl-tRNA. Evidence for this binding was derived from modification of cysteine-81 on EF-Tu with sulfhydryl agents such as N-tosyl-L-phenylalanine chloromethyl ketone and N-ethylmaleimide. In contrast to binding of aminoacyl-tRNA to the classical binding site, which is accompanied by a shielding of cysteine-81 (3), the kirromycin-induced binding of uncharged tRNA and N-acetylaminoacyl-tRNA resulted in an enhanced modification of cysteine-81.
To demonstrate the kirromycin-dependent tRNA binding in a more direct fashion we cross-linked periodate-oxidized tRNA to EF-Tu with [3H]borohydride. Peptide mapping enabled us to identify the cross-linking sites on EF-Tu GDP and EF-Tu GTP. The experiments also resulted in a crosslinking of kirromycin to the protein. The residues involved in the cross-linking of tRNA are both located on domain 1 of the three-dimensional EF-Tu structure, whereas the crosslinking site for the antibiotic is on the opposite side of the protein molecule in domain 2. to a final concentration of 800 ,uM and allowed to proceed for 1 hr at 0°C. Cross-linking was stopped by the addition of 3 vol of 1 M boric acid (pH 6.0), the reaction mixture was exhaustively dialyzed against 0.1 M boric acid (pH 6.0), and an aliquot was analyzed on an Ultrogel AcA44 column in reaction buffer. The remainder was further dialyzed against 0.1 M NH4HCO3 (pH 7.8). Free and coupled tRNA was digested by 200 units of RNase I per mg of tRNA at 37°C for 2 hr. After prolonged dialysis against 0.1 M NH4HCO3 to remove tRNA fragments, thermolytic digestion of the protein was carried out at 35°C for 2 hr [enzyme/substrate ratio, 1:200 (wt/wt)]. The resulting peptides were lyophilized and submitted to fingerprint analysis according to Castel et al. (10) . Fluorograms of the peptide maps were obtained after soaking the paper in the scintillator EN3HANCE (New England Nuclear). The scintillator was allowed to evaporate for 15 min to avoid etching of the x-ray film. Exposure times were between 4 and 10 days at -80°C.
MATERIALS AND METHODS
Abbreviations: EF-Tu, elongation factor Tu; tRNA0xi, periodate-oxidized tRNA.
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When additional HPLC separation of peptides was necessary prior to hydrolysis, it was carried out on a /LBondapak C18 column with a biphasic linear gradient of n-propanol in 10 mM t-butylammonium acetate (pH 6.0).
Manual Edman degradation of peptides was as described by Tomita et al. (11) .
RESULTS
Specificity of the Kirromycin-Dependent Binding of Periodate-Oxidized tRNA to EF-Tu GDP. A first indication that periodate-oxidized tRNA (tRNA0xi) is able to bind to EFTu GDP in the presence of kirromycin is shown in Fig. 1 .
Though not with equal affinity, both tRNA0.i and uncharged tRNA stimulated the modification of cysteine-81 with N-[3H]ethylmaleimide in a way characteristic for binding to the extra site (7). About 4-fold higher concentrations of tRNA0xi than uncharged tRNA were necessary to give a 50% stimulation, indicating that oxidation of tRNA lowered its affinity for EF-Tu. In a control experiment (not shown), the negligible amino acid charging capacity of the tRNAOi preparation indicated that the effect on the modification of cysteine-81 was not caused by remaining amounts of nonoxidized uncharged tRNA. Further evidence for the specificity of the binding is presented in Fig. 2 and EF-Tu interacted in a 1:1 molar ratio. Although our previous modification studies suggested that the EF-Tu GDPkirromycin complex can bind two tRNA molecules simultaneously (7), no radiolabeled complex with a higher molecular weight could be detected in the elution pattern. 4 . They reveal that the radioactive compounds did not precisely coincide with the fluorescamine-stained peptides. It was assumed that cross-linking increased the chromatographic mobility of the peptides concerned (no significant change in electrophoretic mobility was observed). Manual Edman degradation of the 3H-labeled peptides (Fig. 5) the EF-Tu polypeptide chain. It shows that cross-linking was highly specific, indeed, and it occurred to a significant extent at only three positions: lysine-208, lysine-237, and lysine-357. Cross-linking to lysine-208 was the major event in the case of EF-Tu GDP, as was cross-linking to both lysine-237 and lysine-208 in the case of EF-Tu-GTP. No significant peptide labeling was observed in the absence of kirromycin.
Omission of tRNA0x, obliterated labeling of lysine-208 and lysine-237, but not that of lysine-357. This indicated that labeling of the latter residue was due to cross-linking of the antibiotic.
DISCUSSION
The cross-linking experiments of the present investigation locate two tRNA and one kirromycin binding site on the EFTu polypeptide chain.
The two tRNA cross-linking sites become apparent only in the presence of kirromycin. They are distinct in two respects. (i) Topographically (Fig. 7) : one contains lysine-208, tentatively located, as explained later, on the loop between a-helix V and p-strand 6; the other, lysine-237, is located on a-helix VI (13); here we shall refer to them as tRNA crosslinking sites II and I, respectively, for reasons discussed below. (ii) Functionally: cross-linking site II is induced by kirromycin on both EF-Tu GDP and EF-TuwGTP, whereas cross-linking site I is only induced on EF-Tu GTP.
Suggestive evidence that cross-linking site I is associated with the classical tRNA binding site is 3-fold. Preliminary experiments using EF-Tu-GDP crystals treated with guanylyl imidodiphosphate and puromycin followed by x-ray data collection and difference Fourier analysis revealed changes in the electron density above helix VI-i.e., in close proximity of lysine-237 (J. R. Rubin, personal communication). Secondly, aminoacyl-tRNA and 3' terminal fragments thereof protect cysteine-81 at the end of p-strand 2 against modification with N-tosyl-L-phenylalanine chloromethyl ketone (3). This locates the 3' terminus of tRNA in the ternary complex EF-Tu-GTP~aminoacyl-tRNA in the same-region. Finally, E-N-bromoacetyllysyl-tRNA has been reported to crosslink to histidine-66 on strand 1 (14) . All these data support the idea that the region around the tRNA cross-linking site I is very close, if not identical, to the classical tRNA binding site.
On the basis of our previous modification studies on EFTu (see Introduction and ref. 7) , it was concluded that kirro- activity of EF-Tu. It is an intriguing possibility, therefore, that the second tRNA binding site may be also induced on association of the ternary complex EF-Tu-GTP-aminoacyltRNA with the ribosome.
Results recently obtained by cross-linking EF-Tu to tRNA while located on the ribosomes are in accordance with this suggestion (unpublished results). 
